RecruitingPhase 2Phase 3NCT06496997

A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome

Sponsor

Fayoum University

Enrollment

300 participants

Start Date

Aug 1, 2024

Study Type

INTERVENTIONAL

Conditions

Acute Respiratory Distress Syndrome

Summary

The aim of the work is to compare the efficacy of equivalent doses of methylprednisolone, dexamethasone and hydrocortisone in patients with ARDS

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dexamethasone, a drug called Hydrocortisone, and others for people with acute respiratory distress syndrome. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMethylprednisolone

Methylprednisolone at a dose of 1 mg/kg/day (an average dose of 70 mg/day based on 70 kg body weight)

DRUGDexamethasone

Dexamethasone at an equivalent dose of 13 mg/day

DRUGHydrocortisone

Hydrocortisone at an equivalent dose of 350 mg/day

Locations(1)

Fayoum University

Al Fayyum, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06496997

Related Trials

Validation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study

NCT072897111 location

Height Measurement Procedures Influence the Risk of Ventilator-induced Lung Injury in ARDS

NCT075959261 location